Foresite Capital Management V, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ALUMIS INC. | 5,779,348 | 5,896,995 | +117,647 | 56,406,436 | 129,910,800 | 47.94% | +73,504,364 |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,004,050 | 0 | 41,688,156 | 67,954,104 | 25.08% | +26,265,948 |
| Eikon Therapeutics, Inc. | 0 | 1,318,983 | +1,318,983 | 0 | 13,954,840 | 5.15% | +13,954,840 |
| Hims & Hers Health, Inc.(HIMS) | 273,151 | 738,151 | +465,000 | 8,869,213 | 15,324,015 | 5.65% | +6,454,802 |
| Pharvaris N.V. COM | 0 | 194,125 | +194,125 | 0 | 5,484,031 | 2.02% | +5,484,031 |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 265,000 | +265,000 | 0 | 4,107,500 | 1.52% | +4,107,500 |
| Disc Medicine, Inc.(IRON) | 299,069 | 374,069 | +75,000 | 23,749,069 | 23,917,972 | 8.83% | +168,903 |
| Maze Therapeutics, Inc.(MAZE) | 86,291 | 25,905 | -60,386 | 3,575,036 | 773,264 | 0.29% | -2,801,772 |
| Lyell Immunopharma, Inc. | 477,078 | 477,078 | 0 | 14,684,461 | 9,570,185 | 3.53% | -5,114,276 |
| Natera, Inc.(NTRA) | 67,356 | 0 | -67,356 | 15,430,586 | 0 | — | -15,430,586 |